About Orexigen Therapeutics, Inc. (OREX) β Dividend Analysis 2026
OREX is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in OREX shares.
Is OREX a good dividend investment in 2026?
OREX offers a 897.26% forward yield with a 50% payout ratio. Strand Safety Score: 15/100 (Critical Risk). The 5-year dividend CAGR of 0% is modest β investors should weigh current income against growth alternatives.
OREX DRIP calculator β what's the difference?
With DRIP on a $10,000 investment over 10 years, your OREX portfolio grows to $1001.37M vs $11.14M without reinvestment. This is the compound interest effect in action.
OREX dividend growth history & forecast
OREX has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 897.26%.
Company generates negative FCF ($-110M) β borrowing to pay dividends
Debt Leverage0.0Γ Debt/EBITDA
0 / 30 pts
0/30
Company not generating EBITDA β debt servicing risk is elevated
Earnings Momentum-0.0B β -0.1B β -0.0B
15 / 30 pts
15/30
Net income grew in the latest year β positive but trend is unconfirmed
OVERALL ASSESSMENT
High risk of dividend cut β weak fundamentals across multiple factors.
STRAND SCORE
15
/100
Strand Safety Scoreβ’ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.
π OREX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold OREX.
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
π― OREX Income Goal & Break-Even
Dividend Break-Even
1yr
Years for dividends to fully repay your OREX investment of $0.22/share (πΊπΈ US Taxable (15%) Β· 15.00% tax)
$10K invested Β· 10 Years
Dividends earned (DRIP)
$28.65M
Lost to inflation (2.8% CPI)
β$2.5K
Real purchasing power gain
$28.65M
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in OREX for:
Shares needed
14,118
Capital required
$3,147
Monthly income
$2,000
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
π OREX Dividend Payment Schedule
OREX pays quarterly β 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
π°
Apr
May
Jun
π°
Jul
Aug
Sep
π°
Oct
Nov
Dec
π°
10 shares
$4.25 / payment
$17.00 / year after tax
100 shares
$42.50 / payment
$170.00 / year after tax
1,000 shares
$425.00 / payment
$1700.00 / year after tax
π OREX vs Healthcare Benchmarks
How OREX compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend Yieldβ²+894.46% vs sectorBetter
OREX
897.26%
avg
2.80%
5Y Dividend CAGRβΌ-6.80% vs sectorBelow avg
OREX
0.00%
avg
6.80%
Payout Ratioβ²-5.00% vs sectorBetter
OREX
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for OREX sourced from FMP /financial-growth endpoint β real data, not estimates.
ποΈ OREX Insider Activity
No recent SEC filings reported in the last 90 days.
π About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the OREX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β